144 related articles for article (PubMed ID: 11865664)
1. Toxicophores: groups and metabolic routes associated with increased safety risk.
Williams DP; Naisbitt DJ
Curr Opin Drug Discov Devel; 2002 Jan; 5(1):104-15. PubMed ID: 11865664
[TBL] [Abstract][Full Text] [Related]
2. Structural alerts, reactive metabolites, and protein covalent binding: how reliable are these attributes as predictors of drug toxicity?
Kalgutkar AS; Didiuk MT
Chem Biodivers; 2009 Nov; 6(11):2115-37. PubMed ID: 19937848
[TBL] [Abstract][Full Text] [Related]
3. Prediction of a new drug's potential to cause idiosyncratic reactions.
Uetrecht J
Curr Opin Drug Discov Devel; 2001 Jan; 4(1):55-9. PubMed ID: 11727323
[TBL] [Abstract][Full Text] [Related]
4. Future of toxicology--low-dose toxicology and risk--benefit analysis.
Rietjens IM; Alink GM
Chem Res Toxicol; 2006 Aug; 19(8):977-81. PubMed ID: 16918235
[TBL] [Abstract][Full Text] [Related]
5. From toxic precursors to safe drugs. Mechanisms and relevance of idiosyncratic drug reactions.
Petersen KU
Arzneimittelforschung; 2002; 52(6):423-9. PubMed ID: 12109041
[TBL] [Abstract][Full Text] [Related]
6. Idiosyncratic toxicity: mechanistic insights gained from analysis of prior compounds.
Waring JF; Anderson MG
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):59-65. PubMed ID: 15679173
[TBL] [Abstract][Full Text] [Related]
7. Peroxidases: a role in the metabolism and side effects of drugs.
Tafazoli S; O'Brien PJ
Drug Discov Today; 2005 May; 10(9):617-25. PubMed ID: 15894226
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome p450 and chemical toxicology.
Guengerich FP
Chem Res Toxicol; 2008 Jan; 21(1):70-83. PubMed ID: 18052394
[TBL] [Abstract][Full Text] [Related]
9. Future of toxicology-metabolic activation and drug design: challenges and opportunities in chemical toxicology.
Baillie TA
Chem Res Toxicol; 2006 Jul; 19(7):889-93. PubMed ID: 16841955
[TBL] [Abstract][Full Text] [Related]
10. Toxic effects of chemicals: difficulties in extrapolating data from animals to man.
Garattini S
Crit Rev Toxicol; 1985; 16(1):1-29. PubMed ID: 3910353
[TBL] [Abstract][Full Text] [Related]
11. Idiosyncratic drug reactions: past, present, and future.
Uetrecht J
Chem Res Toxicol; 2008 Jan; 21(1):84-92. PubMed ID: 18052104
[TBL] [Abstract][Full Text] [Related]
12. Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment.
Smith DA; Obach RS
Chem Res Toxicol; 2009 Feb; 22(2):267-79. PubMed ID: 19166333
[TBL] [Abstract][Full Text] [Related]
13. Strategies for dealing with reactive intermediates in drug discovery and development.
Nassar AE; Lopez-Anaya A
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):126-36. PubMed ID: 14982156
[TBL] [Abstract][Full Text] [Related]
14. Minimizing metabolic activation during pharmaceutical lead optimization: progress, knowledge gaps and future directions.
Kumar S; Kassahun K; Tschirret-Guth RA; Mitra K; Baillie TA
Curr Opin Drug Discov Devel; 2008 Jan; 11(1):43-52. PubMed ID: 18175266
[TBL] [Abstract][Full Text] [Related]
15. Toxicophores, reactive metabolites and drug safety: when is it a cause for concern?
Kalgutkar AS; Fate G; Didiuk MT; Bauman J
Expert Rev Clin Pharmacol; 2008 Jul; 1(4):515-31. PubMed ID: 24410554
[TBL] [Abstract][Full Text] [Related]
16. Effect of diet on the metabolism and toxicology of drugs.
Ioannides C; Parke DV
J Hum Nutr; 1979 Oct; 33(5):357-66. PubMed ID: 115915
[TBL] [Abstract][Full Text] [Related]
17. In silico toxicology for the pharmaceutical sciences.
Valerio LG
Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
[TBL] [Abstract][Full Text] [Related]
18. The roles of drug metabolism in the pathogenesis of T-cell-mediated drug hypersensitivity.
Lavergne SN; Park BK; Naisbitt DJ
Curr Opin Allergy Clin Immunol; 2008 Aug; 8(4):299-307. PubMed ID: 18596585
[TBL] [Abstract][Full Text] [Related]
19. Predicting toxicities of reactive metabolite-positive drug candidates.
Kalgutkar AS; Dalvie D
Annu Rev Pharmacol Toxicol; 2015; 55():35-54. PubMed ID: 25292426
[TBL] [Abstract][Full Text] [Related]
20. Metabolic activation in drug-induced liver injury.
Leung L; Kalgutkar AS; Obach RS
Drug Metab Rev; 2012 Feb; 44(1):18-33. PubMed ID: 21939431
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]